News About: Pharm. Industry
There are 17 great stock owners having shares worth of more than KRW 100 billion in the pharmaceutical and biopharmaceutical industry
As pharmaceutical and bio stocks have significantly increased starting this year, stock assets of leaders in the pharmaceutical industry and their families have been significantly increased.
In particular, stock asse...
MSD Korea will burden the largest amount of the 2nd pharmaceutical side effect damage relieveIt is known that MSD Korea has took the largest share in the notice of payment for the 2nd pharmaceutical side effect damage relief in 2015.
On the 2nd, the Ministry of Food an...
|
As MERS is getting into the relief stage, now is the time for MRs to come back in the field
Expectation has been increased towards business activities of the pharmaceutical industry in the second half.
According to the pharmaceutical industry concerned on the 2nd, the last June was a nightmare as the number...
Kwang Dong absorbed former GSK employees retired from the ERP, reinforcing capacity of its vaccine business
It is confirmed that the vaccine sales contract of GSK and Kwang Dong Pharmaceutical has led to personnel recruitment.
It has been observed that this is the result of their Early Retirement Program(ERP) and the co-ma...
What is the next movements of domestic pharmaceutical companies recognized in technical strength?
Technical strength of domestic pharmaceutical companies has been recognized in the foreign market, but it still has far ways to go.
According to the industry concerned, new drugs developed by the technology of domest...
Although mid-sized pharmaceutical companies have fallen behind in sales, but not in R&D
While research and development(R&D) of pharmaceutical companies have been accelerated, it is known that the ranking for R&D expenses against sales and their increase rates has been changed a number of times. It is ana...
Samsung Biologics stated “We will become the best CMO in the world”
Samsung Biologics, a biopharmaceutical manufacturing company, declared to become the world’s top CMO recording KRW 2 trillion annual sales by 2025.
After the test production on July 2013, the Factory 1 of Samsung Bio...
SK Chemicals announced the approval for its tetravalent vaccine with the cell cultivation system is drawing near
The SK Chemicals’ tetravalent influenza vaccine, having the cell cultivation system, is expected to acquire an approval soon.
On the 1st, Hoon Kim, Vaccine R&D Director of SK Chemicals, announced at the ‘Global Bio C...
The bizarre phenomenon of the pharmaceutical industry with its 93 price earning ratio without any bubble controversy
The average price earning ratio(PER) of the pharmaceutical industry is observed to be 93.4. PER, a ratio of a company’s current share price compared to its per-share earnings, indicates a number of times for a share p...
Market capitalization of listed pharmaceutical companies increased double while Hanmi Science became the ‘Pharmaceutical Jackpot’
It is known that as expectation grows towards pharmaceutical and bio stocks, market capitalization o listed pharmaceutical companies became double 6 months. Especially, Hanmi Science, a holding company of Hanmi Pharm,...
